Experimental immunoprevention of type I diabetes mellitus.
Service d'Immunologie Clinique, INSERM U25 and CNRS UA 122, Hôpital Necker, Paris, France.
C
C
Boitard
J
J
Timsit
P
P
Sempé
J F
JF
Bach
D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D003920:Diabetes Mellitus / Q000276:immunology / Q000517:prevention & control* / Q000628:therapy; D003921:Diabetes Mellitus, Experimental / Q000276:immunology / Q000517:prevention & control* / Q000628:therapy; D006801:Humans; D007165:Immunosuppression Therapy; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007167:Immunotherapy; D013601:T-Lymphocytes / Q000276:immunology
D000911:Antibodies, Monoclonal; D007166:Immunosuppressive Agents